Icotec AG receives FDA clearance for the commercialization of the VADER®one pedicle screw system
Wednesday, July 10, 2019
icotec AG, a Swiss company, today announced that the VADER®one pedicle screw system has been licensed by the US Food and Drug Administration (FDA) 510 (k) ) for minimally invasive procedures and surgical procedures of the open spine. VADER®one, made from icotec's unique BlackArmor® material, has been designed for secure stabilization and postoperative visualization, which is important after surgery on a spinal tumor.
In a recent publication, the Neurosurgery and Radiation Oncology Group at the Technical University of Munich , Germany, stated: "In terms of postoperative evaluation of residual or recurrent tumors at the periphery of the spinal canal and the spine and for accurate planning of radiotherapy, CFRP * implants have major advantages over standard titanium implants because they generate significantly fewer image artifacts.
VADER®one est fabriqué à partir du matériau unique BlackArmor® carbone/PEEK d'icotec, constitué de fibres de carbone continues combinées au PEEK (polyétheréthercétone) et est produit à l'aide de la technologie de fabrication CFM (Composite Flow Moulding ou moulage par flux de composite) de moulage par injection d'icotec. Ce processus permet d'obtenir des implants non métalliques renforcés en 3 dimensions, offrant à la fois la force et la radiotransparence nécessaires aux patients en oncologie et à leur traitement.
icotec is the only company manufacturing spinal implants in radiolucent composite material from BlackArmor® carbon / PEEK. BlackArmor® implants are biocompatible and have been successfully implanted for more than 15 years. Their translucency to X-ray, CT and MRI makes a significant difference during and after the surgical procedure for assessment of the area of care. In patients with spinal tumors, an optimal delineation of the tumor compared to healthy tissue can facilitate the planning of radiotherapy, improve the treatment by radiosurgery and allow immediate and accurate follow-up of possible relapses (tumor recurrence).
"Our ability to use icotec's BlackArmor® material to stabilize the spine offers advanced-stage tumor patients the ability to consider a wider variety of treatment options with therapeutic planning, dose administration and more. an improved follow-up evaluation, "said Roger Stadler , CEO of icotec AG, Switzerland. "Obtaining FDA clearance, a milestone in our company's history, is a great success for our company and our employees. "
VADER®one implants are intended to restore the integrity of the spine, even in the absence of fusion for a limited time, in patients with advanced tumors involving the thoracic and lumbar spines in which the expectation of life is of insufficient duration to allow the realization of the merger.
icotec AG is a family owned business based in Altstaetten, Switzerland, since 1999. icotec designs and manufactures non-metallic spinal implants made from BlackArmor® (carbon / PEEK). More than 10,000 Icotec BlackArmor® pedicle screws have been implanted in countries other than the United States since their introduction on the market.
For more information, visit our website www.icotec-medical.com or contact us at: media@icotec-medical.com